Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Campone

Showing results (151-160 of 302) with videos related to

Pageof 31
Sort By:
American Journal of Clinical Oncology|June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapyPierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.
Breast Cancer Research : BCR|May 19, 2019
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implicationsPascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, et al.
Journal of Neuro-Oncology|October 21, 2009
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methodsLucie Karayan-Tapon, Véronique Quillien, Joëlle Guilhot, et al.
British Journal of Cancer|January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trialLuc Cabel, Frédérique Berger, Paul Cottu, et al.
Cell Death & Disease|March 1, 2019
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatmentJordan Guillon, Coralie Petit, Marie Moreau, et al.
Oncology and Therapy|March 7, 2017
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER StudyVéronique Diéras, Thomas Bachelot, Mario Campone, et al.
JCO Clinical Cancer Informatics|March 20, 2025
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert RecommendationsLoic Ah-Thiane, Pierre-Etienne Heudel, Mario Campone, et al.
Molecular Cancer|September 9, 2011
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1Mario Campone, Bélinda Noël, Cécile Couriaud, et al.
Cancers|October 14, 2023
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Oncotarget|November 16, 2017
Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patientsElodie Jobard, Olivier Trédan, Thomas Bachelot, et al.
Pageof 31

Showing results (151-160 of 302) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Oncology|June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapyPierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.
Breast Cancer Research : BCR|May 19, 2019
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implicationsPascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, et al.
Journal of Neuro-Oncology|October 21, 2009
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methodsLucie Karayan-Tapon, Véronique Quillien, Joëlle Guilhot, et al.
British Journal of Cancer|January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trialLuc Cabel, Frédérique Berger, Paul Cottu, et al.
Cell Death & Disease|March 1, 2019
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatmentJordan Guillon, Coralie Petit, Marie Moreau, et al.
Oncology and Therapy|March 7, 2017
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER StudyVéronique Diéras, Thomas Bachelot, Mario Campone, et al.
JCO Clinical Cancer Informatics|March 20, 2025
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert RecommendationsLoic Ah-Thiane, Pierre-Etienne Heudel, Mario Campone, et al.
Molecular Cancer|September 9, 2011
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1Mario Campone, Bélinda Noël, Cécile Couriaud, et al.
Cancers|October 14, 2023
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)Valérie Seegers, Guillaume Rousseau, Ke Zhou, et al.
Oncotarget|November 16, 2017
Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patientsElodie Jobard, Olivier Trédan, Thomas Bachelot, et al.
Pageof 31